Dugan Margaret, Chief Medical Officer of Schrodinger Inc. ($SDGR), made one open market sale of company shares worth $29,387 in the last 365 days, with the most recent on October 16, 2025. Her total sales rank 10,834th among 11,678 insiders, below the average of $8.6 million per person and 6.4 transactions. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Dugan Margaret | Chief Medical Officer | A | Stock Option (right to buy) | 283157 | $0.00 | 283,157.0000 | 69,204,899 | 9999.99% | 0.41% |
| Dec. 1, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Dugan Margaret | Chief Medical Officer | A | Stock option (right to buy) | 650000 | $0.00 | 650,000.0000 | 69,204,899 | 9999.99% | 0.94% |
| Dec. 1, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Dugan Margaret | Chief Medical Officer | A | Restricted Stock Units | 55309 | $0.00 | 55,309.0000 | 69,204,899 | 9999.99% | 0.08% |
| Oct. 16, 2025 | Schrodinger, Inc. | $SDGR | Dugan Margaret | Chief Medical Officer | S | Common Stock | 1395 | $21.07 | 24,574.0000 | 73,613,090 | 5.37% | 0.00% |
| May 21, 2025 | BeOne Medicines Ltd. | $ONC | Dugan Margaret | Director | A | Ordinary Shares | 10985 | $0.00 | 56,940.0000 | 1,368,746,793 | 23.90% | 0.00% |
| May 21, 2025 | BeOne Medicines Ltd. | $ONC | Dugan Margaret | Director | A | Share Option (Right to Buy) | 22750 | $0.00 | 22,750.0000 | 1,368,746,793 | 9999.99% | 0.00% |
| March 3, 2025 | Schrodinger, Inc. | $SDGR | Dugan Margaret | Chief Medical Officer | A | Common Stock | 12500 | $0.00 | 25,969.0000 | 72,670,295 | 92.81% | 0.02% |
| March 3, 2025 | Schrodinger, Inc. | $SDGR | Dugan Margaret | Chief Medical Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 72,670,295 | 9999.99% | 0.07% |
| Oct. 15, 2024 | Schrodinger, Inc. | $SDGR | Dugan Margaret | Chief Medical Officer | S | Common Stock | 1531 | $17.78 | 13,469.0000 | 72,813,006 | 10.21% | 0.00% |
| June 5, 2024 | BeOne Medicines Ltd. | $ONC | Dugan Margaret | Director | A | Share Option (Right to Buy) | 34151 | $0.00 | 34,151.0000 | 1,357,034,547 | 9999.99% | 0.00% |
| June 5, 2024 | BeOne Medicines Ltd. | $ONC | Dugan Margaret | Director | A | Ordinary Shares | 16341 | $0.00 | 45,955.0000 | 1,357,034,547 | 55.18% | 0.00% |
| March 4, 2024 | Schrodinger, Inc. | $SDGR | Dugan Margaret | Chief Medical Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 74,986,816 | 9999.99% | 0.08% |
| Aug. 9, 2023 | Schrodinger, Inc. | $SDGR | Dugan Margaret | Chief Medical Officer | A | Common Stock | 15000 | $0.00 | 15,000.0000 | 71,173,419 | 9999.99% | 0.02% |
| Aug. 9, 2023 | Schrodinger, Inc. | $SDGR | Dugan Margaret | Chief Medical Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 71,173,419 | 9999.99% | 0.13% |